Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee…
8 analysts rate NHI Buy on consensus.
Consensus price target: $78.50 (+17.06% upside from $67.06)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| MCCABE ROBERT A JR director | Jun 15, 2026 | Purchase | 890 | $63.77K |
| Mendelsohn D. Eric director, CEO and President | Jun 5, 2026 | Purchase | 1,500 | $103.26K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $378.53M | +12.93% | $142.18M |
| 2024 | $335.18M | +4.8% | $137.99M |
| 2023 | $319.83M | +14.97% | $135.65M |
Stock data for NHI: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics